Table 1 Clinical symptoms of hMPV-positive patientes among the predominant genotypes in Beijing, 2014–2024
Symptoms and signs, n (%) | A2c | A2c111nt-dup | B2 | B2(2024) | P value |
|---|---|---|---|---|---|
(n = 94) | (n = 190) | (n = 31) | (n = 63) | ||
Fever (≥37.3 °C) | 82/92 (89.1) | 170/177 (96.0) | 28/29 (96.6) | 59/61 (96.7) | 0.719 |
<37.3 | 10/92 (10.9) | 7/177 (39.5) | 1/29 (3.4) | 2/61 (3.3) | 0.349 |
37.3–37.9 | 7/92(7.6) | 15/177 (8.5) | 0 (0) | 2/61 (3.3) | |
38–38.9 | 42/92 (45.7) | 87/177 (49.2) | 14/29 (48.3) | 30/61(49.2) | |
≥39 | 33/92 (35.9) | 68/177(38.4) | 14/29 (48.3) | 27 (44.3) | |
Sore throat | 18 (19.1) | 50 (26.3) | 10 (32.3) | 17 (27.0) | 0.525 |
Cough | 90 (95.7) | 171 (90.0) | 30 (96.8) | 57 (90.5) | 0.343 |
Nasal congestion | 15 (16.0) | 49 (25.8) | 9 (29.0) | 19 (30.2) | 0.494 |
Rhinorrhea | 46 (48.9) | 68 (35.8) | 15 (48.4) | 28 (44.4) | 0.277 |
Headache | 1 (1.1) | 9 (4.7) | 4 (12.9) | 3 (4.8) | 0.191 |
Fatigue | 4 (4.3) | 15 (7.9) | 5 (16.1) | 1 (1.6) | 0.133 |
Myalgia | 0 (0) | 12 (6.3) | 1 (3.2) | 1 (1.6) | 0.057 |
Diarrhea | 3 (3.2) | 3 (1.6) | 2 (6.5) | 1 (1.6) | 0.282 |
Abdominal pain | 2 (2.1) | 4 (2.1) | 2 (6.5) | 5 (7.9) | 0.281 |
Disease severity status | |||||
URTI | 35/92 (38.0) | 64/180 (35.6) | 6/30 (20.0) | 50/62 (80.6) | 0.000 |
nsCAP | 48/92 (52.2) | 104/180 (57.8) | 21/30 (70.0) | 12/62 (19.4) | |
sCAP | 9/92 (9.8) | 12/180 (6.6) | 3/30 (10.0) | 0 (0) | |
Inpatient | 45 (47.9) | 73 (38.4) | 14 (45.2) | 5 (7.9) | 0.000 |
ICU admission | 2 (2.1) | 6 (3.2) | 1 (3.2) | 1 (1.6) | 0.881 |
Death in hospital | 0 (0) | 0 (0) | 1(3.2) | 0 (0) | 0.000 |
Hospital length of stay (d) | 8 (6,12) | 8 (5,12) | 7 (16,8) | 8 (6,11) | 0.229 |
Time from illness onset to discharge (d) | 12 (11,16) | 12 (9,15) | 11 (9,12) | 8 (6,11) | 0.187 |
